Company Profiles

driven by the PitchBook Platform

ImaginAb

Description

Developer of engineered antibody fragments for diagnostic imaging and radio immunotherapy. The company's clinical product pipeline comprises prostate stem cell antigen for prostate, bladder and pancreatic cancer; J591 prostate-specific membrane antigen for prostate cancer and T-cell co-receptor for cancer, inflammation and transplantation. It also offers companion imaging agents, pre-clinical in vivo validation, clinical studies translation and custom antibody engineering services.

2007

Founded

PRIVATE

Status

11-50

Employees

Series A3

Latest Deal Type

$5.34M

Latest Deal Amount

$38.6M

Total Amount Raised

Description

Developer of engineered antibody fragments for diagnostic imaging and radio immunotherapy. The company's clinical product pipeline comprises prostate stem cell antigen for prostate, bladder and pancreatic cancer; J591 prostate-specific membrane antigen for prostate cancer and T-cell co-receptor for cancer, inflammation and transplantation. It also offers companion imaging agents, pre-clinical in vivo validation, clinical studies translation and custom antibody engineering services.

Website:

www.imaginab.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Diagnostic Equipment

Primary Office

423 Hindry Avenue Suite D Inglewood, CA 90301United States +1 (310) 645-1211
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore ImaginAb's full profile, request a free trial.

ImaginAb Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

ImaginAb Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

ImaginAb Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Cycad GroupVenture CapitalMinority000 0000000 0000
Mérieux DéveloppementVenture CapitalMinority000 0000000 0000
Momentum BiosciencesVenture CapitalMinority000 0000000 0000
Nextech InvestVenture CapitalMinority000 0000000 0000
Novartis Venture FundsCorporate Venture CapitalMinority000 0000000 0000
Cycad Group Venture Capital
Mérieux Développement Venture Capital
Momentum Biosciences Venture Capital
Nextech Invest Venture Capital
Novartis Venture Funds Corporate Venture Capital

ImaginAb Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Benjamin Chen Ph.DChief Executive Officer & President
Jennifer KepplerChief Operating Officer & President
Jeff QuanChief Financial Officer
Anna Wu Ph.DCo-Founder, Board Member & Chief Scientist
Robert Reiter MDCo-Founder & Chief Medical Advisor
Benjamin Chen Ph.D Chief Executive Officer & President
Jennifer Keppler Chief Operating Officer & President
Jeff Quan Chief Financial Officer
Anna Wu Ph.D Co-Founder, Board Member & Chief Scientist
Robert Reiter MD Co-Founder & Chief Medical Advisor

ImaginAb Board Members (8)

NameRepresentingRoleSinceContact
Info
Abbie Celniker Ph.DSelfDirector000 0000
Campbell Murray MDNovartis Venture FundsDirector000 0000
Isaac Bright MDMérieux DéveloppementDirector000 0000
Jeffrey BaileyImaginAbDirector000 0000
Joesph LimberImaginAbChairman000 0000
Abbie Celniker Ph.D Director Self
Campbell Murray MD Director Novartis Venture Funds
Isaac Bright MD Director Mérieux Développement
Jeffrey Bailey Director ImaginAb
Joesph Limber Chairman ImaginAb
Request full access to PitchBook